Wednesday, 16 April 2014

Could Making Bednets Become a Viable Business?


President Bush handed out hugs and bed nets in Tanzania's rural north on Monday, saying the U.S. is part of a new international effort to provide enough mosquito netting to protect every child between one and five from contracting malaria in this east African nation (Time).
The coverage of the Tanzania stop on the President's Africa trip featured a stop at the A to Z Textile Mills, a local manufacturer of bednets. The news accounts I saw were notable for their lack of controversy - not a mention of paid vs. free distribution - and a focus on the bottom-line: the success of a multi-pronged approach in saving lives.
The visit at A to Z was remarkable as this company has achieved status of what could go right with private sector solutions to health problems: African entrepreneurs creating jobs while improving the health of millions. However, it is also a company that could stand to lose the most if policy-makers are not paying attention; the good news is maybe they are in this case.
Brian Trelstad at The Acumen Fund blog provides four ideas of how policy changes in the allocation of  funding for malaria control and prevention might benefit economic development in the region:
  • Give preference to African manufacturers or suppliers of anti-malarial commodities.
  • For long-lasting bednets, Global Fund-supported projects should award contracts on the basis of delivered costs, not factory prices.
  • Begin to set aside subsidies for the private distribution of nets to complement the free distribution programs.
  • Anticipate the problem of recycling the nets now. In five years, Africans will be throwing away 100 million used bednets a year.
Exploring the intersection of public, private and civil society in comprehensive malaria control and prevention (whether it be through creative capitalism, social businesses, or a Total Market Approach) is one of the more challenging and rewarding (and sometimes frustrating and maddening) places for social marketers to be these days.
- See more at: http://socialmarketing.blogs.com/r_craiig_lefebvres_social/2008/02/could-making-be.html#sthash.BhnSDdlA.dpuf

Angola: First mosquito net factory to produce 2 million units per year



Luanda, Angola, 20 Nov – Angola’s first mosquito net factory, a project budgeted to cost US$5 million, will be built in Benguela, one of the project’s promoters, Paulo Louro said in Luanda Monday.
Speaking to Portuguese news agency Lusa, Louro said that the factory, which was due to go into operation in December 2008, would produce up to 2 million nets per year.
Louro said that December 2008 was the target for starting to produce long-lasting impregnated mosquito nets, with the quality demanded by the World Health organization (WHO), which says that mosquito nets are the most efficient method of fighting malaria, the biggest cause of death amongst under-5s in Africa.
Milton Saraiva, of the National Fight Against Malaria Program, said that construction of the factory was very important as it would provide the population with easy access to mosquito nets.
“As well as making access to nets easier, construction of this factory will make it possible to lower the price to around US$5 per unit, as compared with US$9 at the moment,” Saraiva said. (macauhub)

Factory shows net gains


 
swissinfo  
April 29, 2003 8:11 AM
 
 
TMTL sells 300,000 nets a year (swissinfo)
TMTL sells 300,000 nets a year (swissinfo) (swissinfo)
A chance conversation over a drink led Anthony Haji to become one of Tanzania’s leading mosquito net manufacturers.
 
For 20 years the family’s textile mill in the industrial quarter of Dar es Salaam had been mothballed – put out of business by the second-hand clothing market.
 
RELATED ITEMS
 
Audio
Story
Story
 
 
In 1997, learning of the need for bed nets in the fight against malaria, Haji rushed over to the factory to see whether the machines, which used to produce polyester fabrics, were capable of producing nets.

Two weeks later a sample was ready and he took his first order. In 1998, Haji, a Tanzanian national with a Swiss mother, started production with a staff of 16.

Today he employs 180 people and sells 300,000 nets a year and his Textile Manufacturers of Tanzania (TMTL) is the third player in a thriving domestic market.
 
Sewn up
 
Inside the factory, sewing machines whizz and whirr as dozens of stitchers put together the blue, green and white netting that has been woven on the factory’s 30-year-old German looms.

TMTL’s nets are typically conical or rectangular in shape and come in single, mother and baby, and family size.

Conical nets, which are easier to hang and fold up, are handy in small rooms where beds are used as seats or tables during the day. Rectangular nets hang from string or frames and take up more space.

“All the nets have a 20 centimetre rigid border which in our case is the original polyester fabric which the company used to make 20 years ago,” said Haji.

“The reason for this is that most Tanzanians sleep on the floor on a mattress and they need the border of the net to tuck under their mattress.

“We also devised a very cheap brand with no border made from cut pieces of net that we would otherwise throw away. It’s for the poor man on the street who can really not afford anything else but still needs to be protected from mosquitoes.”
 
Blue mosquito nets prove a bestseller for TMTL
Blue mosquito nets prove a bestseller for TMTL (swissinfo)
 
Do or dye
 
When the factory started its operation, it was able to use up the old stocks of polyester that had lain unused since the machines had fallen idle.

Today, the raw material comes from several countries including Thailand and India.

As for the money Haji took from his first order, he ploughed it straight back into the business, buying a dyeing machine from India.

“Blue is a best seller,” he explained. “The white nets are the cheapest nets to produce because you don’t really need a dye, but, of course, to be able to market a product, there isn’t really a lot you can do to a net other than size and colour.”

“The other practical reason for having colours is that Tanzanians actually sleep in very difficult conditions. They sleep in muddy areas, dusty areas, wet environments, so white gets dirty very quickly.”

TMTL sells most of its nets in and around Dar es Salaam. Over the counter sales play an important role.

About 40 street vendors turn up each week, pay cash for a bundle of 100 nets and disappear. Others share a taxi, which they pile high with nets, before heading off in search of customers.
 
Growing market
 
Tanzania is now by far the largest producer of bed nets in Africa – a far cry from the 1980s when nets were rare in Tanzania and cost between $10 and $15, assuming you could find one.

The boom began in 1994 when one factory in the northern city of Arusha, stimulated partly by a change in the tax structure and partly by changes in other textile markets, began to make ready-made nets at a moderate price for the mass market.

Sunflag’s Mmbu net sold for $4.25 wholesale and $7 retail and annual sales were about quarter of a million a year.

In 1998, another Arusha manufacturer, A-Z Textile Mills entered the market and shortly afterwards TMTL joined the fray.

They were both offered a guaranteed market for a certain number of nets by Population Services International (PSI), an American NGO, which uses commercial marketing techniques to meet public health objectives – a technique known as social marketing.
 
 
""
Tanzanians have a net culture but it is still a major spend for your average person.
""
Anthony Haji, TMTL
 
 
Taxing times
 
Competition has brought a fall in prices and an increase in quality and diversity.

“The first net I ever provided to PSI, I sold at 5,800 shillings in 1998 and at that time the dollar to the shilling was far more favourable than it is today,” recalls Haji.

“Nets today in Tanzania retail at around 3,500 shillings, which is just under $3.50, but wholesale nets are closer to $2.50 so it’s a massive dip in prices but there again the volumes have significantly increased.”

Although Tanzania was one of the first countries in Africa to waive tariffs on netting material, an oversight in last year’s taxation reforms has led to the reintroduction of 20 per cent duty on imported raw materials for net manufacturers.

Haji and his two larger rivals have not yet passed on the extra cost to consumers but the longer they have to wait for reimbursement, the likelier this becomes.
 
Net gains
 
The three factories are capable of producing up to six million nets a year for use at home and in neighbouring countries.

Between them, they sold 1.5 million nets on the domestic market last year and project even better results for 2003.

On average, one net protects two people, which means protection for about three million people a year at current rates of sale.

In an important development last October, the manufacturers agreed to package all their nets for the local market with sachets of insecticide treatment. Since then, they have sold more than half a million of these bundled nets.

“Tanzanians have a net culture but it is still a major spend for your average person,” says Haji.

“Three dollars or 3,500 shillings may not sound much but for a Tanzanian it is a gamble between buying food for his family, paying bus fares to get to work or getting this really expensive piece of equipment which it is hard to believe can save lives in the long term.”

Current Funding for Malaria Implementation



Limited national resources in high burden countries. Although the situation varies widely by region and by country, current national funding covers only a fraction of what is needed for the implementation of malaria control programs, especially in high burden countries. This is particularly true in Africa, where government budgets represent only 18% on average of total malaria funding.[47] In 2003, African leaders affirmed in the Maputo Declaration their commitment to increase financial support for the health sector to 15% of total government expenditure. Today, however, 90% of African countries remain below the 15% threshold.[48] Even if countries were to achieve the 15% target, their expenditures on key malaria interventions would still be substantially less than the estimated need. As shown in Figure I.4, government expenditures on health per capita are the lowest in regions with the highest malaria burden.
Figure I.4: Government expenditure on health in malaria-endemic regions

Note: Government expenditure on health per capita as regional weighted average; % of government expenditure on health as arithmetical average, 15% target agreed by African countries in Maputo Declaration (July 2003)
Source: Analysis based on WHO Health Statistics 2008; 2005 data
According to data from WHO and the main donor organizations, the share of government budget spent on malaria is substantially higher in Asia-Pacific than in Africa and represents the largest source of malaria funding in the Americas and in the Middle East and Eurasia. Detailed regional analyses of funding for malaria are presented in Part III: Regional Strategies.
Major sources of malaria funding. Money spent on malaria in 2007 amounted to an estimated total of ~US$ 1.5 billion (see Figure I.5). One fifth of these funds came from household purchases of malaria products (such as anti-malarial drugs or long-lasting insecticidal nets) principally through the private sector. Approximately 34% of funds came from national government expenditures dedicated to malaria, and the remaining funding came from international donors, which disbursed an estimated US$ 701 million. The Global Fund contributed to half of the disbursements from international donors.[49]
Figure I.5: Current sources of funds spent on malaria

a) Regional funding estimates not available for private household spend and other USAID. Therefore, summing regional funds presented in Part III – Regional Strategies only adds up to approx. $1.1 billion, see appendix 3 for methodology
Source: World Malaria Report 2008. Geneva, World Health Organization, 2008 (Government, UN Agencies, Bilaterals, EU); the Global Fund website; PMI operational plans; USAID website; World Bank Booster Program (see appendix on methodology); 2007 data
The trend is positive for international funding. As Figure I.6 illustrates, unprecedented amounts of money have poured into malaria control since 2004. Disbursements from international donors increased threefold from 2004 to 2007. Commitments for coming years are promising. 2008 disbursements are estimated to be ~US$ 1.1 billion, (more than four times 2004 amount) thanks to expected payouts of previous Global Fund rounds, increased scope of the U.S. President’s Malaria Initiative (PMI) (from 10 countries in 2007 to 15 countries supported in 2008) and the disbursements of money committed in Phase I of the World Bank Booster Program (~67% of Phase I commitments are expected to be disbursed by the end of 2008).
Figure I.6: Evolution of international funding disbursements for malaria

Source: World Malaria Report 2008. Geneva, World Health Organization, 2008 (Government, UN Agencies, Bilaterals, EU); GFATM website; PMI operational plans; USAID website; World Bank Booster Program (see appendix on methodology)
Both the Global Fund (US$ 9.7 billion for 2008-2010)[50] and the World Bank (US$ 41.6 billion for the International Development Association’s 15th replenishment)[51] have been highly successful in advocating for replenishments. While G8 donor countries are still far from reaching the aid pledges made to Africa in 2005 in Gleneagles, individual governments have increased their pledged funds and other donations for malaria. In April 2008, Prime Minister Gordon Brown announced the United Kingdom's government's pledge to donate 20 million bed nets. In July 2008, the President of the United States signed a reauthorization act that could increase US malaria funding to US$ 5 billion over the next five years.[52] The World Bank is preparing Phase II of its Booster program with an aspirational lending target of at least ~ US$ 1.2 billion for sub-Saharan Africa. In addition, the World Bank's Board of Executive Directors has just approved over US$ 500 million for a project to support India’s efforts against malaria and other diseases, for which the amount for malaria could reach US$ 200 million,[53] making it the largest single disease control investment in the history of the World Bank.

Increased Funding for Malaria Research and Development

Figure I.7 shows the steady increase in funding for malaria research and development over the past five years. In 2007, funding for malaria research and development is estimated at ~US$ 422 million. The two major donors (United States’ National Institutes of Health and the Bill and Melinda Gates Foundation) account for ~40% of estimated current funding for R&D. More than 60% of funds are directed to drugs and vaccines.
Figure I.7: Evolution of spending on malaria research and development

Note: Estimated $165M in funding from “other” donors based on Malaria R&D Alliance estimate for 2004; assumes all BMGF malaria funding is for R&D
Source: Bill ∓ Melinda Gates Foundation; National Institutes of Health website; Malaria R&D Alliance (2005)

Tuesday, 15 April 2014

Microbial Misadventures: A Malaria Outbreak Without Mosquitoes



By Rebecca Kreston | April 14, 2014 9:07 am
Microbial Misadventures is a recurring series on Body Horrors looking at instances and incidents where human meets microbe in novel and unusual circumstances that challenge our assumptions about how infections are spread. 
Shout “fire” in a crowded room and watch the occupants fly for the exits. Speak the word “malaria” and watch as all within earshot reach for the nearest can of DEET.  The incontrovertible fact of malaria’s relationship with mosquitos is one that has been known since Sir Ronald Ross discovered the parasite nesting within the belly of a mosquito in 1897. Such is the natural order, an incontestable necessity of the protozoan parasite’s life cycle. Humans, however, are rather adept at bucking that system – see cronuts, labradoodles, and the college bowl ranking system for examples. Also due to the interference of mankind, as a 1995 Taiwanese medical mystery proved, malaria can indeed be spread without the assistance of their obnoxious arthropod cronies.
A photomicrograph of Plasmodium malariae showing the merozoite stage of the parasite’s life cycle. These red blood cells will release merozoite that will eventually develop into male and female gametocytes. Image: CDC.
Malaria is a protozoan parasite of the rather large genus Plasmodium that has long exploited the tenuous relationship between humans and mosquitos for its own unscrupulous replicative means, infecting humans through the the efficient delivery system of the mosquito’s syringe-like proboscis. This disease is nothing new; it has plagued humans since the time of Hippocrates when the Romans avoided the stretch of Pontine marshes for fear of contracting the “bad air” from which malaria derives its name.
While there are over a hundred species of Plasmodium malaria, there are just five species that cause disease in humans. Those five – P. falciparum, P. vivax, P. malariae, P. ovale and P. knowlesi - cause an estimated 200 million infections and 600,000 deaths annually posing an enormous burden upon developing countries that have been unable to eradicate the parasite (1). But for most of us, our relationship with malaria consists solely of what little is heard through the news or, occasionally, an intimate encounter with the disease while sightseeing or working internationally.
This was just the situation in the case of a Taiwanese businessmen who traveled to Nigeria in 1995 and inadvertently caused a small outbreak in a general teaching hospital in Taipei, a country free of malaria since its eradication in the 1960s (2). Until this uncommon outbreak, every single case of malaria in Taipei had been directly traced to an individual’s recent travels to an endemic region.
Two weeks after the hospital admission of our index case, our ill businessman, an additional four patients developed unusual fevers that were identified as being malarial in origin. Yet none of these group of five patients shared a history of blood transfusions nor any common exposures, aside from treatment within the same hospital, that would predispose them to malaria.
The materialization of this infection in unrelated hospitalized patients without any recent history of international travel led, of course, to the supposition that mosquitoes had invaded the hospital, fed on the jet-setting businessmen and had gone on to infect patients. The obvious step in controlling this outbreak  would be to thoroughly hose down the hospital with mosquito repellent with the expectation of putting an end to this imported outbreak. To that end, mosquitos around the hospital were trapped for testing and summarily executed en masse.
An example of an x-ray computed tomography (CT )scanner. Image: NithinRao
However,  surveillance of the hospital’s surrounding neighborhoods produced no evidence of mosquitoes carrying malaria and yet still the parasite surfaced in two more patients. Greater scrutiny into the collective medical history of all infected patients at the hospital surrendered an unusual yet crucial clue that helped to crack this “malaria without the mozzies” mystery: every single patient had undergone a procedure using the same computed tomographic (CT) scanner, an important instrument for medical imaging, and developed symptoms of malaria 11 to 16 days later.
Many CT scanners rely on injecting a patient with a radiocontrast medium that allows for enhanced resolution and imaging of the cast and cut of our organs and arteries. In the case of this outbreak, this particular CT scanner used a device to inject the contrast medium from two catheters, a contrast medium container, and an automatic injector for administrating a pre-measured amount of medium. The catheters were designed to be continuously used and not disposable, as they safely provided a conduit for injection of material. Unfortunately, as described by the researchers detailing the outbreak and its subsequent investigation,
 The computer log sheet noted that the electricity had been interrupted for a short time during the examination of the index case … it was found that approximately 0.25 mL of patient blood was withdrawn back into catheter B when the electricity was interrupted during examination with the Imatron scanner. The density and viscosity of blood is less than that of the contrast medium, so the blood floated to a higher level during the mixing of blood with the contrast medium (2).
This outbreak resulted from the convergence of a series of curious events – a traveler carrying malaria from abroad, a disruptive loss of electricity, a fatal failure of medical technology, and the intravenous delivery of a parasite sans its mosquito partner in crime. A total of six patients were accidentally injected with contrast medium infected with malarial blood from the businessmen. Four would die from complications of the infection.
Nosocomial, or hospital-spread, infections are nothing new but malaria infections usually begin outside of the hospital, not within, and natural transmission of the parasite deeply relies on the little needlenose of mosquitoes. Of course, malaria can be spread by other means – it just needs a helping hand. As keenly demonstrated in Taiwan nearly 20 years ago, the entire ouborous-like life cycle of malaria was bypassed for the far more efficient and dangerous route of direct contact with infected blood.
Bizarre as the Taiwanese case may seem, transfusion-related malaria has consistently proven to be the most common hospital-borne parasitic infection since it was first described in 1911 (3). There have been over 2,000 documented cases showcasing a variety of colorful, man-made methods of spreading malaria, including blood transfusions, organ transplants, or through the always-popular needle-stick injuries.
In 1917, fourteen British soldiers were infected with malaria after receiving intravenous solutions of salvarsan, a medication used to treat syphilis. Though the needle had been changed between patients, the remaining hardware components of the intravenous apparatus had not – as was the case with our Taiwanese outbreak  - and contained infective parasites that went on to kill ten of the infected men (4). In Venezuela in 1987, six cases of malaria were spread among patients infused with antibiotics and intravenous fluids; a vial of the blood clotting protein heparin containing multi-dose treatments was implicated (5). A vial of contaminated multi-dose heparin was also incriminated in a 21-person outbreak in Saudi Arabia (6). As was noted in an article on controlling such iatrogenic incidents,
Two factors combine to make such parenteral transmission of parasites a potentially severe problem when it does occur. First, low index of suspicion results in diagnostic delay and potentially more severe disease. Second, the recipients of component transfusion or organ transplantation are often immunocompromised hosts and thus more likely to develop severe illness or death from the acquired parasitic infection (3).
The transmission of malaria through syringes has also been well demonstrated outside of hospitals, in intravenous drug users that share contaminated needles (7). Though this form of transmission is but a strange blip in the hundreds of thousands of malaria cases that occur via the blood-sucking bite of a desperate mosquito, these sorts of cases have implications for the maintenance of infection-control practices of both hospital equipment and staff. Malaria already has the upper hand in our public health battle to fight global diseases; it doesn’t need a boost from within our hospital walls.